Latest News in the pharma Industry

All

Irvine Scientific introduces PRIME-XV T cell CDM for immunotherapy applications

Irvine Scientific introduces PRIME-XV T cell CDM for immunotherapy applications

23 Jan 2017

The first chemically-defined, animal component-free, cell culture medium for T cells.

Read more 
Molecule shows ability to thwart pathogens’ genetic resistance to antibiotic

Molecule shows ability to thwart pathogens’ genetic resistance to antibiotic

23 Jan 2017

The molecule, which is a PPMO, will likely be ready for testing in humans in about 3 years.

Read more 
Endo agreement to resolve FTE investigation and litigation

Endo agreement to resolve FTE investigation and litigation

23 Jan 2017

No admission of wrongdoing, No monetary payment by Endo.

Read more 
BMS, Ono Pharma and Merck resolve PD-1 antibody patent litigation

BMS, Ono Pharma and Merck resolve PD-1 antibody patent litigation

22 Jan 2017

Merck to pay BMS and Ono royalties on global sales of Keytruda through 2026, and lump-sum payment of $625 million.

Read more 
Concert Pharmaceuticals receives FDA orphan drug designation for CTP-656 for the treatment of CF

Concert Pharmaceuticals receives FDA orphan drug designation for CTP-656 for the treatment of CF

22 Jan 2017

Topline results from the Phase II trial are expected by year-end 2017.

Read more 
EMA validates Gilead’s MAA for investigational chronic Hep C therapy

EMA validates Gilead’s MAA for investigational chronic Hep C therapy

22 Jan 2017

Sofosbuvir/Velpatasvir/Voxilaprevir cranted an accelerated assessment by the EMA.

Read more 
Mylan acquires Cold-EEZE brand to further expand OTC business

Mylan acquires Cold-EEZE brand to further expand OTC business

22 Jan 2017

Cold-EEZE will become Mylan's largest US OTC brand franchise.

Read more 
FDA approves Allergan's Rhofade cream, 1% for persistent facial erythema

FDA approves Allergan's Rhofade cream, 1% for persistent facial erythema

19 Jan 2017

Once-daily treatment reduces persistent facial erythema associated with rosacea through 12 hours.

Read more 
Opdivo demonstrated efficacy and improved survival in patients with previously treated advanced gastric cancer

Opdivo demonstrated efficacy and improved survival in patients with previously treated advanced gastric cancer

19 Jan 2017

Opdivo demonstrated a 37% reduction in the risk of death compared to placebo.

Read more 
I Holland hosts a live webinar to help customers  maximise their tablet tooling life

I Holland hosts a live webinar to help customers maximise their tablet tooling life

19 Jan 2017

Getting the most out of punches and dies with a simple and powerful tooling management system.

Read more 
Takeda and Ovid Therapeutics shake on innovative collaboration for TAK-935 in rare pediatric epilepsies

Takeda and Ovid Therapeutics shake on innovative collaboration for TAK-935 in rare pediatric epilepsies

19 Jan 2017

Collaboration between pharma and biotech underscores potential for new approaches to partnering.

Read more 
Sartorius Stedim Biotech supports mainstream adoption of Quality by Design

Sartorius Stedim Biotech supports mainstream adoption of Quality by Design

18 Jan 2017

Unique technology portfolio enables design space characterization, effective translation to the large-scale and enhanced process analytics.

Read more